Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis

One of the target drugs for plaque psoriasis treatment is apremilast, which is a selective phosphodiesterase 4 (PDE4) inhibitor. In this study, 34 moderate-to-severe and severe plaque psoriasis patients from Russia were treated with apremilast for 26 weeks. This allowed us to observe the effectivene...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pers Med
Autori principali: Verbenko, Dmitry A., Karamova, Arfenya E., Artamonova, Olga G., Deryabin, Dmitry G., Rakitko, Alexander, Chernitsov, Alexandr, Krasnenko, Anna, Elmuratov, Artem, Solomka, Victoria S., Kubanov, Alexey A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7823747/
https://ncbi.nlm.nih.gov/pubmed/33383665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11010020
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi